[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"relapsed-or-refractory-rr-follicular-lymphoma-fl\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:relapsed-or-refractory-rr-follicular-lymphoma-fl":18},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":4,"acronym":4,"eligibilityCriteria":4,"healthyVolunteers":11,"sex":14,"minAge":4,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":15,"phases":4,"briefSummary":16,"conditions":17,"keywords":4,"overallStatus":22,"whyStopped":4,"lastUpdateSubmitDate":23,"lastUpdatePostDateStruct":24,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":27,"locationsCount":4},"100486845","a-compassionate-use-cu-program-of-odronextamab-100486845",false,"NCT05619367","A Compassionate Use (CU) Program of Odronextamab","ALL","EXPANDED_ACCESS","Provide compassionate use of odronextamab",[18,19,20,21],"Relapsed or Refractory (R\u002FR) Follicular Lymphoma (FL)","Diffuse Large B-Cell Lymphoma (DLBCL)","B-Cell Non-Hodgkin Lymphoma (NHL)","High-Grade B-Cell Lymphoma (HGBCL)","AVAILABLE","2025-12-22",{"date":25,"type":26},"2025-12-23","ACTUAL",{"name":28,"class":29},"Regeneron Pharmaceuticals","INDUSTRY"]